← Back to Search

Dietary Supplement

Cardiovascular Effects of EVOO in Healthy Reproductive-aged Women

N/A
Waitlist Available
Led By Erin A Morris, MD
Research Sponsored by University of Vermont Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
* Women are eligible to participate if they are between the ages of 18 and 40, in good health, with regular menstrual cycles and no prior pregnancies.
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year

Summary

This study aims to compare changes in cardiovascular function and markers of inflammation and metabolic dysfunction in women randomized to treatment with extra virgin olive oil (EVOO) versus those randomized to treatment with a control oil low in oleic acid and phenols for 8 weeks.

Eligible Conditions
  • High Blood Pressure
  • Vascular Stiffness

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Arterial Beta Stiffness Index
Arterial distensibility
Arterial pulse wave velocity
+1 more
Secondary study objectives
B-type natriuretic peptide (BNP)
C-reactive protein
Cardiac output
+9 more

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Extra Virgin Olive OilExperimental Treatment1 Intervention
Group II: Control OilPlacebo Group1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Extra Virgin Olive Oil
2019
N/A
~50

Find a Location

Who is running the clinical trial?

University of Vermont Medical CenterLead Sponsor
42 Previous Clinical Trials
25,754 Total Patients Enrolled
Erin A Morris, MDPrincipal InvestigatorUniversity of Vermont Medical Center
~6 spots leftby Dec 2025